Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAMIVUDINE Cause Hepatic cirrhosis? 144 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Hepatic cirrhosis have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 0.9% of all adverse event reports for LAMIVUDINE.

144
Reports of Hepatic cirrhosis with LAMIVUDINE
0.9%
of all LAMIVUDINE reports
20
Deaths
82
Hospitalizations

How Dangerous Is Hepatic cirrhosis From LAMIVUDINE?

Of the 144 reports, 20 (13.9%) resulted in death, 82 (56.9%) required hospitalization, and 8 (5.6%) were considered life-threatening.

Is Hepatic cirrhosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does LAMIVUDINE Cause?

Foetal exposure during pregnancy (1,905) Virologic failure (1,894) Drug resistance (1,889) Pathogen resistance (1,733) Viral mutation identified (1,631) Treatment failure (933) Exposure during pregnancy (846) Drug interaction (744) Drug ineffective (726) Immune reconstitution inflammatory syndrome (625)

What Other Drugs Cause Hepatic cirrhosis?

ADALIMUMAB (1,760) METHOTREXATE (1,650) ETANERCEPT (931) TOCILIZUMAB (903) RITUXIMAB (863) INFLIXIMAB (831) ABATACEPT (824) HYDROXYCHLOROQUINE (807) LEFLUNOMIDE (780) SULFASALAZINE (760)

Which LAMIVUDINE Alternatives Have Lower Hepatic cirrhosis Risk?

LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE LAMIVUDINE vs LAMIVUDINE\TENOFOVIR LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE LAMIVUDINE vs LAMOTRIGINE

Related Pages

LAMIVUDINE Full Profile All Hepatic cirrhosis Reports All Drugs Causing Hepatic cirrhosis LAMIVUDINE Demographics